- CA$33.62m
- CA$43.57m
- CA$87.19m
Brief: NeuPath Health Q1 Adjusted EBITDA CAD 1.5 Million
Canada's NeuPath Health Q4 revenue rises on increased patient visits, new services
Brief: NeuPath Health Q4 Adjusted EBITDA CAD 1 Million
Brief: Neupath Health Announces Renewal Of Normal Course Issuer Bid
Clinic operator NeuPath's Q3 revenue beats on fluoroscopy demand
Brief: NeuPath Health Q3 Adjusted EBITDA CAD 1.5 Million
Canada's NeuPath Q2 revenue up 25%, beats estimates
Brief: NeuPath Health Q1 Adjusted EBITDA CAD 1.3 Million
Brief: NeuPath Health Q4 Adjusted EBITDA CAD 900 Thousand
Brief: Neupath Health Secures New Credit Facilities To Drive Growth And To Refinance Existing Debt
Brief: NeuPath Health Q3 Adjusted EBITDA CAD 700 Thousand
Brief: NeuPath Health Q2 Adjusted EBITDA CAD 1.3 Million
Brief: NeuPath Health Q1 Adjusted EBITDA CAD 900 Thousand
Brief: NeuPath Health Q4 Adjusted EBITDA CAD 800 Thousand
Brief: NeuPath Announces Clinic Acquisition
Brief: NeuPath Health Q3 Adjusted EBITDA CAD 700 Thousand
Brief: Neupath Health Delivers Strong Quarterly Revenues And Improves Cash Position
Brief: Neupath Announces The Positive Resolution Of Its Outstanding HST Matter With The CRA
Brief: Neupath Health Delivers Record Quarterly Revenues And Opens New Fluoroscopy Suite To Patients